Clinical TrialID 5342
Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms
NCT04325880
Ureteral Stent|Stent Related Symptoms
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5342
- Evidence Id
- 5342
- Core Evidence Id
- 5342
- Source Clinical Trial Id
- 5328
- Herb2 Clinical Trial Id
- HBCT005328
- Nct Id
- NCT04325880
- Title
- Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms
- Status
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Ureteral Stent|Stent Related Symptoms
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Mirabegron 50 MG|DRUG: Tamsulosin|DRUG: Solifenacin Succinate 10 MG|DRUG: Placebo oral tablet
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 240
- Outcome Measure
- Improvement in stent related symptoms using ureteral stent symptoms questionnaire (USSQ), The effect of the assigned treatment on improvement of stent related symptoms will be assessed at the time of stent removal using ureteral stent symptoms questionnaire (USSQ), 4 weeks
- Sponsor Collaborator
- Mansoura University
- Funded By
- OTHER
- Location
- Urology and Nephrology Center, Mansoura, DK, 35516, Egypt
- Other Id
- AE 24320
- Start Date
- 2021-12-01
- Primary Completion Date
- 2022-06-01
- Completion Date
- 2022-07-01
- First Posted
- 2020-03-30
- Results First Posted
- Last Update Posted
- 2021-11-23
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT04325880
- Title Cn
- Title En
- Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms
- Bilingual Status
- semi_complete